| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8746079 | Journal of Global Antimicrobial Resistance | 2018 | 21 Pages |
Abstract
These data demonstrate that prescription of anti-TB drugs varied greatly across clinical diagnostic categories, treatment history and drug susceptibility profiles of TB patients. The World Health Organization (WHO)-endorsed standard regimen should be more extensively employed under conditions where drug susceptibility testing is unavailable in order to guide clinicians to formulate a suitable treatment regimen for TB patients.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Jun An, Xuejuan Bai, Mengqiu Gao, Naihui Chu, Hairong Huang, Hongyin Xu, Xiuping Zhang, Baoxia Li, Cailiu Huang, Haixia Cai, Fengqin Zhang, Yu Pang, Liang Li,